Maria Fernanda Lopez Garcia
Maria Fernanda Lopez Garcia
Unknown affiliation
Verified email at
Cited by
Cited by
FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer
N Turner, A Pearson, R Sharpe, M Lambros, F Geyer, MA Lopez-Garcia, ...
Cancer research 70 (5), 2085-2094, 2010
Breast cancer precursors revisited: molecular features and progression pathways
MA Lopez‐Garcia, FC Geyer, M Lacroix‐Triki, C Marchió, JS Reis‐Filho
Histopathology 57 (2), 171-192, 2010
Micro‐RNA signature of the epithelial–mesenchymal transition in endometrial carcinosarcoma
MÁ Castilla, G Moreno‐Bueno, L Romero‐Pérez, KV De Vijver, ...
The Journal of pathology 223 (1), 72-80, 2011
Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer
KJ Dedes, R Natrajan, MB Lambros, FC Geyer, MA Lopez-Garcia, ...
European journal of cancer 47 (1), 138-150, 2011
Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple‐negative and basal‐like breast cancers
D Wetterskog, MA Lopez‐Garcia, MB Lambros, R A'Hern, FC Geyer, ...
The Journal of pathology 226 (1), 84-96, 2012
The molecular pathology of hereditary breast cancer
J Palacios, MJ Robles Frías, MA Castilla, MA Lopez-Garcia, J Benitez
Pathobiology 75 (2), 85-94, 2008
The molecular underpinning of lobular histological growth pattern: a genome‐wide transcriptomic analysis of invasive lobular carcinomas and grade‐and molecular subtype‐matched …
B Weigelt, FC Geyer, R Natrajan, MA Lopez‐Garcia, AS Ahmad, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2010
MicroRNA-200 family modulation in distinct breast cancer phenotypes
MÁ Castilla, J Díaz-Martín, D Sarrió, L Romero-Pérez, MÁ López-García, ...
PloS one 7 (10), e47709, 2012
Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology
R Colomer, I Aranda-López, J Albanell, T García-Caballero, E Ciruelos, ...
Clinical and Translational Oncology 20, 815-826, 2018
Pathogenetic pathways in ovarian endometrioid adenocarcinoma: a molecular study of 29 cases
JT Geyer, MA López-García, C Sánchez-Estevez, D Sarrió, ...
The American journal of surgical pathology 33 (8), 1157-1163, 2009
Nuclear TAZ expression associates with the triple-negative phenotype in breast cancer
J Diaz-Martin, MÁ López-García, L Romero-Pérez, MR Atienza-Amores, ...
Endocrine-related cancer 22 (3), 443-454, 2015
ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma
L Romero-Pérez, MÁ López-García, J Díaz-Martín, M Biscuola, ...
Modern Pathology 26 (11), 1514-1524, 2013
Pathologic and molecular features of uterine carcinosarcomas
MA Lopez-Garcia, J Palacios
Seminars in diagnostic pathology 27 (4), 274-286, 2010
PPM1D gene amplification and overexpression in breast cancer: a qRT-PCR and chromogenic in situ hybridization study
MB Lambros, R Natrajan, FC Geyer, MA Lopez-Garcia, KJ Dedes, ...
Modern Pathology 23 (10), 1334-1345, 2010
The biological, clinical and prognostic implications of p53 transcriptional pathways in breast cancers
TM Abdel‐Fatah, DG Powe, J Agboola, M Adamowicz‐Brice, RW Blamey, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2010
VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer
MÁ Castilla, MÁ López-García, MR Atienza, JM Rosa-Rosa, J Díaz-Martín, ...
Endocrine-related cancer 21 (4), 587-599, 2014
Identification of cellular and genetic drivers of breast cancer heterogeneity in genetically engineered mouse tumour models
L Melchor, G Molyneux, A Mackay, FA Magnay, M Atienza, H Kendrick, ...
The Journal of pathology 233 (2), 124-137, 2014
Genetic characterization of breast cancer and implications for clinical management
FC Geyer, MA Lopez‐Garcia, MB Lambros, JS Reis‐Filho
Journal of cellular and molecular medicine 13 (10), 4090-4103, 2009
Biological properties of hydroxytyrosol and its derivatives
JG Fernández-Bolaños, Ó López, MÁ López-García, A Marset
Olive oil-constituents, quality, health properties and bioconversions, 2012
MAP17 and SGLT1 protein expression levels as prognostic markers for cervical tumor patient survival
M Perez, JM Praena-Fernandez, B Felipe-Abrio, MA Lopez-Garcia, ...
PLoS One 8 (2), e56169, 2013
The system can't perform the operation now. Try again later.
Articles 1–20